Role of cardiac inflammation in right ventricular failure

XQ Sun, A Abbate, HJ Bogaard - Cardiovascular Research, 2017 - academic.oup.com
Right ventricular failure (RVF) is the main determinant of mortality in patients with pulmonary
arterial hypertension (PAH). Although the exact pathophysiology underlying RVF remains …

Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations

I Striz - Clinical science, 2017 - portlandpress.com
Interleukin 1 (IL-1) family is a group of cytokines with multiple local and systemic effects,
which regulates both innate and adaptive immune responses. Generally, most IL-1 family …

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center …

B Van Tassell, V Mihalick, G Thomas… - Journal of Translational …, 2022 - Springer
Background Heart failure (HF) is a global leading cause of mortality despite implementation
of guideline directed therapy which warrants a need for novel treatment strategies. Proof-of …

Interleukin-1 and the NLRP3 inflammasome in pericardial disease

A Vecchié, MG Del Buono, GJ Chiabrando… - Current Cardiology …, 2021 - Springer
Abstract Purpose of Review Pericarditis is a generally benign disease, although
complications and/or recurrences may occur in up to 30% of cases. New evidence on the …

Interleukin-1 blockade for the treatment of pericarditis

LF Buckley, MM Viscusi… - European Heart …, 2018 - academic.oup.com
Pericarditis is a debilitating condition that results from profound inflammation of the
pericardial tissue. Between 10 and 15% of first episodes of acute pericarditis will be followed …

Role of targeted therapy in dilated cardiomyopathy: the challenging road toward a personalized approach

JAJ Verdonschot, MR Hazebroek, JS Ware… - Journal of the …, 2019 - Am Heart Assoc
Dilated cardiomyopathy (DCM) is characterized by LV (left ventricular) or biventricular
systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary …

Therapeutic strategies for virus-negative myocarditis: a comprehensive review

G De Luca, C Campochiaro, S Sartorelli… - European journal of …, 2020 - Elsevier
Virus-negative or autoimmune myocarditis (VNM) is an inflammatory disease affecting the
myocardium that may occur as a distinct disease with exclusive cardiac involvement, or in …

Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update

ON Obi, EE Lower, RP Baughman - Expert Review of Clinical …, 2021 - Taylor & Francis
Introduction: Sarcoidosis is a multi-organ disease with a wide range of clinical
manifestations and outcomes. A quarter of sarcoidosis patients require long-term treatment …

The anti-atherosclerosis effect of anakinra, a recombinant human interleukin-1 receptor antagonist, in apolipoprotein E knockout mice

EJ Ku, BR Kim, JI Lee, YK Lee, TJ Oh, HC Jang… - International Journal of …, 2022 - mdpi.com
Interleukin (IL)-1β plays an important role in atherosclerosis pathogenesis. We aimed to
investigate the effect of anakinra, a recombinant human IL-1 receptor antagonist, on the …

Exploring functional differences between the right and left ventricles to better understand right ventricular dysfunction

J Bernal-Ramirez, MC Díaz-Vesga… - Oxidative Medicine …, 2021 - Wiley Online Library
The right and left ventricles have traditionally been studied as individual entities.
Furthermore, modifications found in diseased left ventricles are assumed to influence on …